Topical Application of Low-concentration (0.01%) Atropine on the Human Eye With Fast and Slow Myopia Progression Rate

• Status: Completed
• Trial end date: 2020-08-31
• Target enrollment: 0
• Participant gender: All

Summary

Our project is a 24-month longitudinal randomized controlled trial that aims to investigate the myopia development after topical application of 0.01% atropine in children with either fast or slow myopia progression classified according to their initial electro-retinal responses. This will help elucidate the effectiveness of using low concentration atropine for myopia control in children with different myopia progression rates.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: The Hong Kong Polytechnic University
• Collaborator: The University of Hong Kong
• Treatments: Atropine; Lubricant Eye Drops

Criteria

Inclusion Criteria:

• Age between 7 and 10 years

• Good general health and no family history of ocular diseases

• No current or history of epilepsy or asthma

• Myopia : -0.50 to -1.00 D (inclusive, both eyes)

• Astigmatism : ≤ 0.50 D

• No hyperopia, amblyopia or strabismus

• No reported ocular eye diseases or disorders

• No drug allergy